1251 - 1300 of 6230 Results
Title
Year
-
OPENTitle: Pandemic Tic‐like Behaviors Following Social Media ConsumptionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2932End Page: 2935Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28800Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28800Citation Count: 65
- Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial2021OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1
- Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease2021OPENTitle: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2969End Page: 2971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28799Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28799Citation Count: 14
-
OPENTitle: Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1456End Page: 1460Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28616Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28616Citation Count: 5
- Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up2021OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2257Citation Count: 15
- Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity study2021OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2101Citation Count: 13
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2344Citation Count: 13
- Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary2021OPENTitle: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contraryJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/brb3.2220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2220Citation Count: 7
-
OPENTitle: Olfactory impairment in Wilson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2022Citation Count: 14
-
OPENTitle: Comparison between four published definitions of hyposmia in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2258Citation Count: 7
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12526Citation Count: 30
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 35
- Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease2021OPENTitle: Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 2Start Page: 441End Page: 449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15165Citation Count: 32
- Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study2021OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 169
-
OPENTitle: Germline Saturation Mutagenesis Induces Skeletal Phenotypes in MiceJournal Name: Journal of Bone and Mineral ResearchPublisher: Oxford University Press (OUP)Vol: 36Issue #: 8Start Page: 1548End Page: 1565Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jbmr.4323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8862308Citation Count: 8
- Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology2021OPENTitle: Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurologyJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 30Issue #: 4Start Page: 974End Page: 983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jgc4.1470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgc4.1470Citation Count: 24
-
OPENTitle: Differentiation of multiple system atrophy subtypes by gray matter atrophyJournal Name: Journal of NeuroimagingPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jon.12927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jon.12927Citation Count: 8
- fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflow2020OPENTitle: fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflowJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 1270End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15283Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15283Citation Count: 6
- Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they model2020OPENTitle: Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they modelJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15275Citation Count: 7
- Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein2021OPENTitle: Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synucleinJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 99Issue #: 4Start Page: 1161End Page: 1176Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jnr.24782Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.24782Citation Count: 32
- Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease2021OPENTitle: Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 302End Page: 314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28849Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28849Citation Count: 25
-
OPENTitle: The contribution of behavioral features to caregiver burden in FTLD spectrum disordersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 9Start Page: 1635End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12494Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9160199Citation Count: 22
- Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum2021OPENTitle: Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 7Start Page: 1370End Page: 1382Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12480Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12480Citation Count: 33
-
OPENTitle: Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 12Start Page: 1976End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12353Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12353Citation Count: 81
-
OPENTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9160203Citation Count: 8
- Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease2021OPENTitle: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 984End Page: 1004Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12254Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12254Citation Count: 37
-
OPENTitle: Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 9Start Page: 1474End Page: 1486Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12310Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12310Citation Count: 52
- Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?2020OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 3
- A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets2020OPENTitle: A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasetsJournal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00092-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00092-yCitation Count: 28
- Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary2020OPENTitle: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and CommentaryJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 7End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00220-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00220-5.pdfCitation Count: 46
- Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®2020OPENTitle: Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®Journal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-020-00087-6Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-020-00087-6Citation Count: 29
- Can kinematic parameters of 3D reach-to-target movements be used as a proxy for clinical outcome measures in chronic stroke rehabilitation? An exploratory study2020OPENTitle: Can kinematic parameters of 3D reach-to-target movements be used as a proxy for clinical outcome measures in chronic stroke rehabilitation? An exploratory studyJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-020-00730-1Best OA location URL: https://jneuroengrehab.biomedcentral.com/track/pdf/10.1186/s12984-020-00730-1Citation Count: 10
-
OPENTitle: Microglial burden, activation and dystrophy patterns in frontotemporal lobar degenerationJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-020-01907-0Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-020-01907-0Citation Count: 42
- The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease2020OPENTitle: The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 2Start Page: 448End Page: 454Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-020-10156-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-020-10156-3.pdfCitation Count: 24
-
OPENTitle: Thalamic morphology predicts the onset of freezing of gait in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00163-0Best OA location URL: https://www.nature.com/articles/s41531-021-00163-0.pdfCitation Count: 30
-
OPENTitle: Pallidal stimulation as treatment for camptocormia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00151-wBest OA location URL: https://www.nature.com/articles/s41531-020-00151-w.pdfCitation Count: 19
- TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease2021OPENTitle: TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00200-yBest OA location URL: https://www.nature.com/articles/s41531-021-00200-y.pdfCitation Count: 6
- Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue2021OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://escholarship.org/content/qt0nc5b6ht/qt0nc5b6ht.pdfCitation Count: 42
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture2021OPENTitle: Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 3Start Page: 294End Page: 303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00785-3Best OA location URL: http://orbilu.uni.lu/handle/10993/46268Citation Count: 314
- Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease2021OPENTitle: Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 787End Page: 793Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-021-00847-6Best OA location URL: https://europepmc.org/articles/pmc8459648?pdf=renderCitation Count: 116
- Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis2021OPENTitle: Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesisJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 53Issue #: 2Start Page: 143End Page: 146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-020-00773-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8130821Citation Count: 292
-
OPENTitle: Brain proteome-wide association study implicates novel proteins in depression pathogenesisJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 24Issue #: 6Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-021-00832-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530461Citation Count: 139
- Reliability and validity of the novel Italian version of the 14-item Resilience Scale (RS-14) in adults2021OPENTitle: Reliability and validity of the novel Italian version of the 14-item Resilience Scale (RS-14) in adultsJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 5Start Page: 3079End Page: 3087Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10072-021-05784-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-021-05784-0.pdfCitation Count: 7
- Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
- Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study2021OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 23
- Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis2021OPENTitle: Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database AnalysisJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 435End Page: 448Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00309-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00309-5.pdfCitation Count: 12
- MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain2021OPENTitle: MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse BrainJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2529End Page: 2540Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01130-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01130-6.pdfCitation Count: 20